According to Weil Pharmaceutical's announcement, Gao Zhengsong, a shareholder holding more than 5% of the company's shares, pledged 3.175 million shares to Cathay Pacific Haitong Securities Co., Ltd. on August 18, 2026, accounting for 22.50% of its shares and 2.34% of the company's total share capital. The pledge maturity date was August 18, 2027, and the funds were used for his own capital requirements; Gao Zhengsong released the pledge of 3.175,000 shares on August 19, 2026, accounting for 22.50% of the company's total share capital. As of the disclosure date of the announcement, Gao Zhengsong held 14.112 million shares, with a shareholding ratio of 10.42%, and pledged 6.35 million shares, accounting for 45.00% of its shares and 4.69% of the company's total share capital.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.